A story in Thursday's AANP SmartBrief referenced a story about the cholesterol drug Vytorin. Vytorin is a product of a joint venture between Schering-Plough and Merck.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||